文献速递医学人工智能与信息学临床试验与 GCP流行病学与生物统计

机器学习在临床研究中的作用:转变未来证据生成

The role of machine learning in clinical research: transforming the future of evidence generation.
PubMed 文献 · Trials · 2021-08-16

本文综述了多利益相关方会议关于机器学习(ML)应用于临床试验设计、实施与分析的现状与前景;会议覆盖试验前阶段、队列选择与参与者管理、数据收集与分析,指出ML有望提升临床研究效率与质量,但证据基础不足且存在操作与理念障碍。

要点

  • ML在临床试验前阶段、队列选择与参与者管理、数据收集与分析中有应用前景。
  • 多个领域的同行评审证据尚缺乏,需填补证据缺口。
  • ML应用面临操作与理念障碍,需多利益相关方协同解决。

核心结论

  • ML有望提升临床研究的效率与质量,但存在显著障碍,需填补证据缺口。

研究设计与样本

  • 综述多利益相关方会议记录,参会者包括生物医学与ML研究者、FDA代表、AI技术与数据分析公司、非营利组织、患者倡导组织及制药公司。

主要发现

  • ML在临床试验前阶段、队列选择与参与者管理、数据收集与分析方面有贡献。
  • 多个领域的同行评审证据缺乏。
  • 会议重点关注ML在临床研究中的操作与理念障碍。

临床怎么用

  • 在临床研究设计中可关注ML在试验前阶段、队列选择与数据收集分析中的应用潜力。
  • 应用ML时需注意操作与理念障碍,并关注证据基础不足的领域。

局限性

  • 多个领域的同行评审证据缺乏。
  • 存在操作与理念障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Interest in the application of machine learning (ML) to the design, conduct, and analysis of clinical trials has grown, but the evidence base for such applications has not been surveyed. This manuscript reviews the proceedings of a multi-stakeholder conference to discuss the current and future state of ML for clinical research. Key areas of clinical trial methodology in which ML holds particular promise and priority areas for further investigation are presented alongside a narrative review of evidence supporting the use of ML across the clinical trial spectrum. RESULTS: Conference attendees included stakeholders, such as biomedical and ML researchers, representatives from the US Food and Drug Administration (FDA), artificial intelligence technology and data analytics companies, non-profit organizations, patient advocacy groups, and pharmaceutical companies. ML contributions to clinical research were highlighted in the pre-trial phase, cohort selection and participant management, and data collection and analysis. A particular focus was paid to the operational and philosophical barriers to ML in clinical research. Peer-reviewed evidence was noted to be lacking in several areas. CONCLUSIONS: ML holds great promise for improving the efficiency and quality of clinical research, but substantial barriers remain, the surmounting of which will require addressing significant gaps in evidence.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Weissler EH, Naumann T, Andersson T, et al. The role of machine learning in clinical research: transforming the future of evidence generation. Trials. 2021. PMID: 34399832. doi:10.1186/s13063-021-05489-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。